Nam & Nam, Inc. t/a Sam Sung Tofu FDA Warning (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on January 24, 2017
Executive Summary
The FDA issued a warning letter to Nam & Nam, Inc. t/a Sam Sung Tofu on January 24, 2017 citing misbranding, labeling violations. The letter was issued by Baltimore District Office.
Detailed Analysis
False Claims and Regulatory Violations
Your Sam Sung Tofu label bears a “Cholesterol Free” claim but fails to meet the requirements of 21 CFR 101.62(d)(i)(D), which states that if the food contains less than 2 mg of cholesterol per reference amount customarily consumed without the benefit of special processing, alteration, formulation, or reformulation to lower cholesterol content, then the product needs to be labeled to disclose that cholesterol is not usually present in the food (e.g., “applesauce, a cholesterol-free food”).
In addition, your Sam Sung Tofu product bears a “Good Source of Protein” nutrient content claim. Under 21 CFR 101.13(n), nutrition labeling in accordance with 21 CFR 101.9 must be provided for any food for which a nutrient content claim is made. Under 21 CFR 101.9(c)(7)(i), a statement of the correct amount of protein per serving expressed as percent of Daily Value (DV) must be given if a protein claim is made for the product. However your Sam Sung Tofu product fails to provide the percent DV of protein as required under 21 CFR 101.9(c)(7)(i). Therefore, your product is misbranded under section 403(r)(1)(A) of the Act and section 403(q) of the Act [21 U.S.C. § 343(q)], because it does not provide information in accordance with 21 CFR 101.9(c)(7)(i) on the percent DV of protein for which a
Potential Health Risks
Consumers should be aware of potential risks associated with products from Nam & Nam, Inc. t/a Sam Sung Tofu.
Regulatory Context
The net quantity of content declaration is not in accordance with 21 CFR 101.7(j)(1) which requires the declaration to be expressed both in ounces, with identification by weight or by liquid measure and, if applicable (1 pound or 1 pint or more) followed in parentheses by a declaration in pounds for weight units, with any remainder in terms of ounces or common or decimal fractions of the pound.
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Nam & Nam, Inc. t/a Sam Sung Tofu?
- The FDA issued a warning letter citing misbranding, labeling violations related to their products or manufacturing practices.
- Are Nam & Nam, Inc. t/a Sam Sung Tofu products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have misbranding that may affect product safety.
- What should I do if I've used Nam & Nam, Inc. t/a Sam Sung Tofu products?
- If you have used products from Nam & Nam, Inc. t/a Sam Sung Tofu and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter